Dr. Gary Shooter

Chief Wound Healing Consultant

Gary Shooter has a PhD in Protein Chemistry from Adelaide University with over 30 years of experience in academic- and industry-based research and development projects. Much of his early career was focused on the development, production and characterisation of growth factors. Subsequently, Dr Shooter lead the Tissue Repair and Regeneration Program at Queensland University of Technology and was involved in a wide range of projects including chronic wound proteomics and the development of novel bioactive matrices for enhanced wound healing. Dr Shooter was also involved in establishing the Wound Management & Innovation Cooperative Research Centre where he led the Enabling Technologies Program between 2012-2014. From 2004-2019 Dr Shooter was the Director of R&D at Tissue Therapies Ltd (latter Factor Therapeutics) where he progressed a wound-healing drug candidate from discovery through to Phase IIb clinical trials for treating Venous Leg Ulcers. During this position, Dr Shooter gained broad expertise in the development of a biologic product covering cGMP manufacturing, CMC, toxicology, regulatory affairs and clinical trial design.

Scroll to Top